Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global cell culture market is experiencing a significant surge in demand, driven by the prevalence of various chronic and infectious diseases worldwide and the need for advanced treatment methods. Cell culture techniques have gained prominence in the pharmaceutical industry, particularly for studying the biochemistry of cells and developing biological compounds like antibodies. These antibodies play a crucial role in the development of vaccines to combat chronic and infectious illnesses, making cell culture a vital aspect of the healthcare industry.

Cell Culture Technique and Vaccine Development

Cell culture's increasing popularity is attributed to its application in studying cell physiology and biochemistry. The awareness of its potential for producing biological compounds like antibodies and recombinant proteins is driving the growth of the cell culture market. Biopharmaceutical companies and researchers are actively utilizing cell culture to develop vaccines against various chronic and infectious diseases, with promising outcomes in drug discovery and vaccine development. As the World Health Organization (WHO) reports approximately 41 million deaths due to chronic diseases, the demand for robust biopharmaceutical development is expected to continue driving the cell culture market forward.

Drug Screening and Development Driving Market Growth

The escalating number of deaths caused by chronic diseases has accelerated drug screening and development, leading the cell culture market towards maturity. The demand for biopharmaceuticals is projected to grow rapidly as public health gains greater importance globally. The COVID-19 pandemic showcased the critical need for vaccine development and drug screening efforts, which are likely to persist beyond the pandemic. The collaboration among stakeholders and growing focus on public health are expected to foster a conducive business environment in the cell culture market.

North America Leads with a Strong Presence of Major Market Players

North America is at the forefront of the global cell culture market, driven by sustained demand for personalized medicine and a high concentration of major market players. The US, in particular, has emerged as a global hub for drug research and development, attracting significant investment in its healthcare industry. This has facilitated the growth of the cell culture market in the region, positioning North America as a leader amidst stiff competition among big pharmaceutical organizations.

Key Market Players Shaping the Industry

Several prominent players are contributing to the growth of the global cell culture market. Some of the major market players include Merck KGaA (Germany), Biospherix Ltd. (US), Danaher Corporation (US), ANGUS Chemical Company (US), Corning Incorporated (US), Thermo Fisher Scientific Inc. (US), Adolf Kuhner AG (Switzerland), Meissner Filtration Products Inc. (US), SeraCare Life Sciences Inc. (US), Lonza Group AG (Switzerland), Cellexus (UK), and PromoCell GmbH (Germany).

1. Executive Summary

1.1. Global Cell Culture Market Outlook, 2018 - 2030 (US$ Million)
1.2. Global Cell Culture Market Incremental Opportunity, 2018 - 2030 (US$ Million)
1.3. Key Industry Trends

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
  - 2.2.1.1. Driver 1
  - 2.2.1.2. Driver 2
- 2.2.2. Restraints
  - 2.2.2.1. Restraint 1
  - 2.2.2.2. Restraint 2
- 2.2.3. Market Opportunities Matrix
2.3. Porters Five Forces Analysis
2.4. Regulatory Guidelines & Reimbursement Scenario
2.5. Covid-19 Impact Analysis

3. Global Cell Culture Market Outlook, 2018 - 2030

3.1. Global Cell Culture Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
- 3.1.1. Key Highlights
  - 3.1.1.1. Equipment
    - 3.1.1.1.1. Incubators
    - 3.1.1.1.2. Bioreactors
    - 3.1.1.1.3. Cryostorage Equipment
    - 3.1.1.1.4. Accessories
  - 3.1.1.2. Consumables
    - 3.1.1.2.1. Reagents
    - 3.1.1.2.2. Sera
    - 3.1.1.2.3. Media
    - 3.1.1.2.4. Others
- 3.1.2. BPS Analysis/Market Attractiveness Analysis
3.2. Global Cell Culture Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
- 3.2.1. Key Highlights
  - 3.2.1.1. Diagnostics
  - 3.2.1.2. Monoclonal Antibodies Production
  - 3.2.1.3. Drug Research & Development
  - 3.2.1.4. Vaccines Production
  - 3.2.1.5. Regenerative Medicines
  - 3.2.1.6. Tissue Engineering
  - 3.2.1.7. Others
- 3.2.2. BPS Analysis/Market Attractiveness Analysis
3.3. Global Cell Culture Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
- 3.3.1. Key Highlights
  - 3.3.1.1. Pharmaceutical & Biotech Companies
  - 3.3.1.2. Diagnostic Centers
  - 3.3.1.3. Academic & Research Institutes
  - 3.3.1.4. Others
- 3.3.2. BPS Analysis/Market Attractiveness Analysis
3.4. Global Cell Culture Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Rest of the World
- 3.4.2. BPS Analysis/Market Attractiveness Analysis

4. North America Cell Culture Market Outlook, 2018 - 2030

4.1. North America Cell Culture Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
- 4.1.1. Key Highlights
  - 4.1.1.1. Equipment
    - 4.1.1.1.1. Incubators
    - 4.1.1.1.2. Bioreactors
    - 4.1.1.1.3. Cryostorage Equipment
    - 4.1.1.1.4. Accessories
  - 4.1.1.2. Consumables
    - 4.1.1.2.1. Reagents
    - 4.1.1.2.2. Sera
    - 4.1.1.2.3. Media
    - 4.1.1.2.4. Others
- 4.1.2. BPS Analysis/Market Attractiveness Analysis
4.2. North America Cell Culture Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
- 4.2.1. Key Highlights
  - 4.2.1.1. Diagnostics
  - 4.2.1.2. Monoclonal Antibodies Production
  - 4.2.1.3. Drug Research & Development
  - 4.2.1.4. Vaccines Production
  - 4.2.1.5. Regenerative Medicines
  - 4.2.1.6. Tissue Engineering
  - 4.2.1.7. Others
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Cell Culture Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
- 4.3.1. Key Highlights
  - 4.3.1.1. Pharmaceutical & Biotech Companies
  - 4.3.1.2. Diagnostic Centers
  - 4.3.1.3. Academic & Research Institutes
  - 4.3.1.4. Others
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Cell Culture Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S.
  - 4.4.1.2. Canada
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cell Culture Market Outlook, 2018 - 2030

5.1. Europe Cell Culture Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
- 5.1.1. Key Highlights
  - 5.1.1.1. Equipment
    - 5.1.1.1.1. Incubators
    - 5.1.1.1.2. Bioreactors
    - 5.1.1.1.3. Cryostorage Equipment
    - 5.1.1.1.4. Accessories
  - 5.1.1.2. Consumables
    - 5.1.1.2.1. Reagents
    - 5.1.1.2.2. Sera
    - 5.1.1.2.3. Media
    - 5.1.1.2.4. Others
- 5.1.2. BPS Analysis/Market Attractiveness Analysis
5.2. Europe Cell Culture Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
- 5.2.1. Key Highlights
  - 5.2.1.1. Diagnostics
  - 5.2.1.2. Monoclonal Antibodies Production
  - 5.2.1.3. Drug Research & Development
  - 5.2.1.4. Vaccines Production
  - 5.2.1.5. Regenerative Medicines
  - 5.2.1.6. Tissue Engineering
  - 5.2.1.7. Others
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Cell Culture Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
- 5.3.1. Key Highlights
  - 5.3.1.1. Pharmaceutical & Biotech Companies
  - 5.3.1.2. Diagnostic Centers
  - 5.3.1.3. Academic & Research Institutes
  - 5.3.1.4. Others
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Cell Culture Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany
  - 5.4.1.2. France
  - 5.4.1.3. U.K.
  - 5.4.1.4. Italy
  - 5.4.1.5. Spain
  - 5.4.1.6. Rest of Europe
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cell Culture Market Outlook, 2018 - 2030

6.1. Asia Pacific Cell Culture Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
- 6.1.1. Key Highlights
  - 6.1.1.1. Equipment
    - 6.1.1.1.1. Incubators
    - 6.1.1.1.2. Bioreactors
    - 6.1.1.1.3. Cryostorage Equipment
    - 6.1.1.1.4. Accessories
  - 6.1.1.2. Consumables
    - 6.1.1.2.1. Reagents
    - 6.1.1.2.2. Sera
    - 6.1.1.2.3. Media
    - 6.1.1.2.4. Others
- 6.1.2. BPS Analysis/Market Attractiveness Analysis
6.2. Asia Pacific Cell Culture Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
- 6.2.1. Key Highlights
  - 6.2.1.1. Diagnostics
  - 6.2.1.2. Monoclonal Antibodies Production
  - 6.2.1.3. Drug Research & Development
  - 6.2.1.4. Vaccines Production
  - 6.2.1.5. Regenerative Medicines
  - 6.2.1.6. Tissue Engineering
  - 6.2.1.7. Others
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Cell Culture Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
- 6.3.1. Key Highlights
  - 6.3.1.1. Pharmaceutical & Biotech Companies
  - 6.3.1.2. Diagnostic Centers
  - 6.3.1.3. Academic & Research Institutes
  - 6.3.1.4. Others
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Cell Culture Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
- 6.4.1. Key Highlights
  - 6.4.1.1. China
  - 6.4.1.2. Japan
  - 6.4.1.3. India
  - 6.4.1.4. South Korea
  - 6.4.1.5. Australia & New Zealand
  - 6.4.1.6. Rest of Asia Pacific
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Rest of the World Cell Culture Market Outlook, 2018 - 2030

7.1. Rest of the World Cell Culture Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
- 7.1.1. Key Highlights
  - 7.1.1.1. Equipment
    - 7.1.1.1.1. Incubators
    - 7.1.1.1.2. Bioreactors
    - 7.1.1.1.3. Cryostorage Equipment
    - 7.1.1.1.4. Accessories
  - 7.1.1.2. Consumables
    - 7.1.1.2.1. Reagents
    - 7.1.1.2.2. Sera
    - 7.1.1.2.3. Media
    - 7.1.1.2.4. Others
- 7.1.2. BPS Analysis/Market Attractiveness Analysis
7.2. Rest of the World Cell Culture Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
- 7.2.1. Key Highlights
  - 7.2.1.1. Diagnostics
  - 7.2.1.2. Monoclonal Antibodies Production
  - 7.2.1.3. Drug Research & Development
  - 7.2.1.4. Vaccines Production
  - 7.2.1.5. Regenerative Medicines
  - 7.2.1.6. Tissue Engineering
  - 7.2.1.7. Others
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Rest of the World Cell Culture Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
- 7.3.1. Key Highlights
  - 7.3.1.1. Pharmaceutical & Biotech Companies
  - 7.3.1.2. Diagnostic Centers
  - 7.3.1.3. Academic & Research Institutes
  - 7.3.1.4. Others
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Rest of the World Cell Culture Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
- 7.4.1. Key Highlights
  - 7.4.1.1. Latin America
  - 7.4.1.2. Middle East & Africa
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Competitive Landscape

8.1. Company Market Share Analysis
8.2. Company Profiles
- 8.2.1. Danaher Corporation
  - 8.2.1.1. Company Overview
  - 8.2.1.2. Financial Overview
  - 8.2.1.3. Product Portfolio
  - 8.2.1.4. Recent Developments
- 8.2.2. Sartorius AG
- 8.2.3. Merck KgaA
- 8.2.4. Thermo Fisher Scientific Inc.
- 8.2.5. PromoCell GmbH
- 8.2.6. Corning Incorporated
- 8.2.7. BioSpherix, Ltd.
- 8.2.8. Others

9. Appendix

9.1. Research Methodology
9.2. Report Assumptions
9.3. Acronyms and Abbreviations